KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Cash from Financing Activities: 2017-2025

Historic Cash from Financing Activities for Elanco Animal Health (ELAN) over the last 8 years, with Sep 2025 value amounting to -$153.0 million.

  • Elanco Animal Health's Cash from Financing Activities rose 88.58% to -$153.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$289.0 million, marking a year-over-year increase of 81.93%. This contributed to the annual value of -$1.5 billion for FY2024, which is 1697.59% down from last year.
  • According to the latest figures from Q3 2025, Elanco Animal Health's Cash from Financing Activities is -$153.0 million, which was up 1.92% from -$156.0 million recorded in Q2 2025.
  • Over the past 5 years, Elanco Animal Health's Cash from Financing Activities peaked at $231.0 million during Q3 2021, and registered a low of -$1.3 billion during Q3 2024.
  • For the 3-year period, Elanco Animal Health's Cash from Financing Activities averaged around -$166.5 million, with its median value being -$93.0 million (2024).
  • As far as peak fluctuations go, Elanco Animal Health's Cash from Financing Activities soared by 344.44% in 2021, and later tumbled by 10,100.00% in 2022.
  • Elanco Animal Health's Cash from Financing Activities (Quarterly) stood at $44.0 million in 2021, then tumbled by 290.91% to -$84.0 million in 2022, then plummeted by 65.48% to -$139.0 million in 2023, then skyrocketed by 76.98% to -$32.0 million in 2024, then skyrocketed by 88.58% to -$153.0 million in 2025.
  • Its Cash from Financing Activities stands at -$153.0 million for Q3 2025, versus -$156.0 million for Q2 2025 and $52.0 million for Q1 2025.